| pubmed-article:19566763 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19566763 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19566763 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:19566763 | lifeskim:mentions | umls-concept:C0036341 | lld:lifeskim |
| pubmed-article:19566763 | lifeskim:mentions | umls-concept:C0073393 | lld:lifeskim |
| pubmed-article:19566763 | lifeskim:mentions | umls-concept:C0205487 | lld:lifeskim |
| pubmed-article:19566763 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:19566763 | lifeskim:mentions | umls-concept:C1096776 | lld:lifeskim |
| pubmed-article:19566763 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:19566763 | lifeskim:mentions | umls-concept:C0084572 | lld:lifeskim |
| pubmed-article:19566763 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:19566763 | pubmed:dateCreated | 2009-7-1 | lld:pubmed |
| pubmed-article:19566763 | pubmed:abstractText | Perospirone is classified as a second-generation antipsychotic agent for the treatment of schizophrenia. Perospirone binds with high affinity to serotonin 5-HT2A receptors and dopamine D2 receptors. There are no reports of clinical comparisons of perospirone and risperidone in multicenter studies. To clarify the clinical traits of perospirone in the treatment of schizophrenia, the clinical efficacies and side-effects of perospirone and risperidone were compared in a randomized clinical multicenter trial. | lld:pubmed |
| pubmed-article:19566763 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19566763 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19566763 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19566763 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19566763 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19566763 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19566763 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19566763 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19566763 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19566763 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:19566763 | pubmed:issn | 1440-1819 | lld:pubmed |
| pubmed-article:19566763 | pubmed:author | pubmed-author:KeyM KMK | lld:pubmed |
| pubmed-article:19566763 | pubmed:author | pubmed-author:MatsumotoNaok... | lld:pubmed |
| pubmed-article:19566763 | pubmed:author | pubmed-author:MorikawaMasay... | lld:pubmed |
| pubmed-article:19566763 | pubmed:author | pubmed-author:KishimotoTosh... | lld:pubmed |
| pubmed-article:19566763 | pubmed:author | pubmed-author:YonedaHiroshi... | lld:pubmed |
| pubmed-article:19566763 | pubmed:author | pubmed-author:KatoMasakiM | lld:pubmed |
| pubmed-article:19566763 | pubmed:author | pubmed-author:OkugawaGakuG | lld:pubmed |
| pubmed-article:19566763 | pubmed:author | pubmed-author:KinoshitaTosh... | lld:pubmed |
| pubmed-article:19566763 | pubmed:author | pubmed-author:ShinosakiKazu... | lld:pubmed |
| pubmed-article:19566763 | pubmed:author | pubmed-author:WakenoMasatak... | lld:pubmed |
| pubmed-article:19566763 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19566763 | pubmed:volume | 63 | lld:pubmed |
| pubmed-article:19566763 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19566763 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19566763 | pubmed:pagination | 322-8 | lld:pubmed |
| pubmed-article:19566763 | pubmed:meshHeading | pubmed-meshheading:19566763... | lld:pubmed |
| pubmed-article:19566763 | pubmed:meshHeading | pubmed-meshheading:19566763... | lld:pubmed |
| pubmed-article:19566763 | pubmed:meshHeading | pubmed-meshheading:19566763... | lld:pubmed |
| pubmed-article:19566763 | pubmed:meshHeading | pubmed-meshheading:19566763... | lld:pubmed |
| pubmed-article:19566763 | pubmed:meshHeading | pubmed-meshheading:19566763... | lld:pubmed |
| pubmed-article:19566763 | pubmed:meshHeading | pubmed-meshheading:19566763... | lld:pubmed |
| pubmed-article:19566763 | pubmed:meshHeading | pubmed-meshheading:19566763... | lld:pubmed |
| pubmed-article:19566763 | pubmed:meshHeading | pubmed-meshheading:19566763... | lld:pubmed |
| pubmed-article:19566763 | pubmed:meshHeading | pubmed-meshheading:19566763... | lld:pubmed |
| pubmed-article:19566763 | pubmed:meshHeading | pubmed-meshheading:19566763... | lld:pubmed |
| pubmed-article:19566763 | pubmed:meshHeading | pubmed-meshheading:19566763... | lld:pubmed |
| pubmed-article:19566763 | pubmed:meshHeading | pubmed-meshheading:19566763... | lld:pubmed |
| pubmed-article:19566763 | pubmed:meshHeading | pubmed-meshheading:19566763... | lld:pubmed |
| pubmed-article:19566763 | pubmed:meshHeading | pubmed-meshheading:19566763... | lld:pubmed |
| pubmed-article:19566763 | pubmed:meshHeading | pubmed-meshheading:19566763... | lld:pubmed |
| pubmed-article:19566763 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19566763 | pubmed:articleTitle | Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study. | lld:pubmed |
| pubmed-article:19566763 | pubmed:affiliation | Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan. okugawa@hirakata.kmu.ac.jp | lld:pubmed |
| pubmed-article:19566763 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19566763 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:19566763 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:19566763 | pubmed:publicationType | Multicenter Study | lld:pubmed |
